Meyler's Side Effects of Cardiovascular DrugsElsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. Each year, heart disease kills more people than cancer. Patients are treated by a variety of specialists and primary care practitioners, depending on the organ system involved. This volume enables practitioners to assess the adverse effects of the complete range of drugs used in cardiovascular medicine, including antihypertensive drugs, and drugs used in the treatment of heart failure, angina, angina pectoris, and cardiac arrhythmia and enable practitioners to prescribe preventative treatments with medications such as blood pressure reducers, aspirin, and cholesterol-lowering drugs, as well as drugs used for more aggressive therapy.The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used.This volume is critical for any health professional involved in the administration of cardiovascular mediations.
The book is divided into six sections:
|
Other editions - View all
Common terms and phrases
ACE inhibitors acetazolamide acute adenosine adverse effects amiodarone amiodarone-induced amlodipine angina angioedema angiotensin antiarrhythmic antibodies anticoagulant antidysrhythmic drugs antihypertensive artery associated atenolol atrial fibrillation beta-adrenoceptor antagonists beta-blockers blood pressure bradycardia calcium channel blockers captopril cardiac Cardiol Cardiovasc cardiovascular cause chronic clearance Clin Pharmacol Ther clinical clonidine congestive heart failure coronary developed diabetes digitalis digoxin digoxin concentration diltiazem disease disopyramide diuretics dofetilide dosage dose double-blind dysrhythmias edema efficacy enalapril enzyme flecainide furosemide glyceryl trinitrate healthy hepatic hyperkalemia hypertension hypotension increased induced infusion inhibition interaction intravenous Lancet lidocaine liver long-term losartan mannitol metabolism metoprolol mexiletine mg/day mmol/l myocardial infarction ng/ml nifedipine occurred oral patients taking pharmacokinetics placebo placebo-controlled potassium potential procainamide prolonged propafenone propranolol pulmonary QT interval quinidine randomized reactions receptor antagonists reduced renal insufficiency reported risk serum sildenafil sinus rhythm skin sotalol spironolactone symptoms syndrome therapy thiazide tion torsade de pointes toxicity treatment ventricular tachycardia verapamil warfarin withdrawal